Aug 01, 2019
Three diagnostics codes added to private reimbursement schedule in England
The Clinical Coding and Schedule Development (CCSD) group develop and maintains procedural and diagnostics nomenclature for private payers in England.

The CCSD Group has approved the following diagnostic codes for publication to the CCSD Schedule in May 2019 with a recommended adoption date being the 1st of August 2019:
  • Hereditary Angioedema (HAE) SERPING 1 gene (0635G)
  • Primary Hyperoxaluria Panel (3547G)
  • Myeloid Panel (3018G)
See full details here.
This website uses cookies to ensure you get the best experience on our website. By carrying on browsing, you are giving your consent for us to set cookies.

Learn more
Ok, I agree
Subscribe to newsletter
Subscribe to our newsletter to get regular updates from us on the changes of reimbursement systems (>100 reimbursement stakeholders in 12 EU countries)